FCF Grants Awarded to Massachusetts General Hospital
Total grants: 6
- Dissecting and Harnessing SIK Tumor Suppressor Function in FLC — Principal investigator(s): Nabeel Bardeesy — 2025
- Fibrolamellar Carcinoma Cell Line Derivation and Characterization — Principal investigator(s): Nabeel Bardeesy — 2025
- Elucidation of nuclear-mitochondrial signaling by DNAJ-PKAc to define targeted vulnerabilities in FLC — Principal investigator(s): Nabeel M. Bardeesy — 2022
- Fibrolamellar carcinoma model development and analysis — Principal investigator(s): Nabeel Bardeesy — 2020
- Targeting DNAJB1-PRKACA driven signaling dependencies in FLC — Principal investigator(s): John Gordan, Nabeel Bardeesy — 2019
- Flipping the switch on PKA: synthetic lethal approaches to block PKA-driven tumor growth in fibrolamellar liver cancer — Principal investigator(s): John Gordan, Nabeel Bardeesy — 2016
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded to Massachusetts General Hospital.